Serum adiponectin in chronic hepatitis C and B

Journal of Viral Hepatitis

Volumn 14, Issue 8, 2007, Pages 577-583

  Siagris, D ^a,b   Vafiadis, G ^a   Michalaki, M ^a   Lekkou, A ^a   Starakis, I ^a   Makri, M ^a   Margaritis, V ^a   Christofidou, M ^a   Tsamandas, A C ^a   Labropoulou Karatza, C ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b NONE   (Greece)

Author keywords

Adiponectin; Alcohol; Genotypes; Hepatitis B virus; Hepatitis C virus; Histopathology

Indexed keywords

ADIPONECTIN; ALKALINE PHOSPHATASE; ALPHA INTERFERON; ASPARTATE AMINOTRANSFERASE; C PEPTIDE; GLOBULIN; HEPATITIS B SURFACE ANTIGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LAMIVUDINE; RIBAVIRIN; VIRUS RNA;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MARKER; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER HISTOLOGY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PARAMETER; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX RATIO;

ADIPONECTIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BIOPSY; C-REACTIVE PROTEIN; CHOLESTEROL; DNA, VIRAL; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GLOBULINS; HEPACIVIRUS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HISTOCYTOCHEMISTRY; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; RNA, VIRAL; TRIGLYCERIDES;

EID: 34447572621     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2007.00850.x     Document Type: Article

References (33)

1. Weyer C, Funahashi T, Tanaka, S et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001 86 : 1930 1935.
2. Berg AH, Combs TP, Du X, Brownlee M, Sherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001 7 : 947 953.
3. Chinetti G, Zawadski C, Fruchart JC, Staels B. Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARα, PPARγ and LXR. Biochem Biophys Res Commun 2004 314 : 151 158.
4. Gil-Campos M, Canete R, Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 2004 23 (5) : 963 974.
5. Roden M. Mechanism of disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab 2006 2 (6 335 348.
6. Bajaj M, Suraamornkul S, Piper, P et al. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab 2004 89 : 200 206.
7. Pagano C, Soardo G, Esposito, W et al. Plasma adiponectin is decreased in non-alcoholic fatty liver disease. Eur J Endocrinol 2005 152 : 113 118.
8. Yokoyama H, Hirose H, Ohgo H, Saito I. Inverse association between serum adiponectin level and transaminase activities in Japanese male workers. J Hepatol 2004 41 : 19 24.
9. Targher G, Bertolini L, Rodella, S et al. Associations between plasma adiponectin concentrations and liver histology in patients with non-alcoholic fatty liver disease. Clin Endocrinol 2006 64 : 679 683.
10. Musso G, Gambino R, De Michieli, F et al. The postprandial phase as a link between systemic lipid peroxidation and liver injury in NASH. Am J Gastroenterol 2006 101 : 1 9.
11. Ouchi N, Kihara S, Arita, Y et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signalling through a camp-dependent pathway. Circulation 2000 102 : 1296 1301.
12. Kobayashi H, Ouchi N, Kihara, S et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 2004 94 : 27 31.
13. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. The fat-derived hormone adiponectin alleviates alcoholic and non-alcoholic fatty liver diseases in mice. J Clin Invest 2003 112 : 91 100.
14. Custro N, Carroccio A, Ganci, A et al. Glucose homeostasis in chronic viral hepatitis and liver cirrhosis. Diabetes Metab 2001 27 : 476 481.
15. Hui JM, Sud A, Farrell, GC et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression. Gastroenterology 2003 125 : 1695 1704.
16. Petit J-M, Minello A, Jooste, V et al. Decreased plasma adiponectin concentrations are closely related to steatosis in hepatitis C virus infected patients. J Clin Endocrinol Metab 2005 90 : 2240 2243.
17. Jonsson JR, Moschen AR, Hickman, IJ et al. Adiponectin and its receptors in patients with chronic hepatitis C. J Hepatol 2005 43 : 929 936.
18. Liu C-J, Chen P-J, Jeng, Y-M et al. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C. J Hepatol 2005 43 : 235 242.
19. Wang AY-H, Hickman IJ, Richards AA, Whitehead JP, Prins JB, MacDonald GA. High molecular weight adiponectin correlates with insulin sensitivity in patients with hepatitis C genotype 3 but not genotype 1 infection. Am J Gastroenterol 2005 100 : 2717 2723.
20. Tietge UJ, Boker KH, Manns MP, Bahr MJ. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. Am J Physiol Endocrinol Metab 2004 287 : E82 E92.
21. Neumeier M, Hellerbrand C, Gäbele, E et al. Adiponectin and its receptors in rodent models of fatty liver disease and liver cirrhosis. World J Gastroenterol 2006 12 (34 5490 5494.
22. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972 18 : 499 502.
23. VanItalie TB. Prevalence of obesity. Endocrinol Metab Clin North Am 1996 25 : 887 905.
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985 28 : 412 419.
25. Ishak K, Baptista A, Bianchi, L et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995 22 : 696 699.
26. Burt AD, Mutton A, Day CP. Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol 1998 15 : 246 258.
27. Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 2004 40 : 46 54.
28. Kaser S, Moschen AR, Cayon, A et al. Adiponectin and its receptors in nonalcoholic steatohepatitis. Gut 2005 54 : 117 121.
29. Arita Y, Kihara S, Ouchi, N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999 257 : 79 83.
30. Tacke F, Wüstefeld T, Horn, R et al. High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo. J Hepatol 2005 42 : 666 673.
31. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002 36 (Suppl. 1 35 46.
32. Stejkal D, Ruzicka V, Fanfrdlova G, Kolar V, Bartek J. High adiponectin and TNF-α levels in moderate drinkers suffering from liver steatosis: comparison with non-drinkers suffering from similar hepatopathy. Biomed Pap 2005 149 (1 93 99.
33. Tilg H, Wilmer A, Vogel, W et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992 103 : 264 274.